| Company Name: |
ACROBiosystems Gold
|
| Tel: |
18514007688 |
| Email: |
jiaxin.zhao@acrobiosystems.com |
| Products Intro: |
Product Name:PD-1
|
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Products Intro: |
Product Name:α-Synuclein E46K human
|
| Company Name: |
Shanghai Huzhen Industrial Co., LTD
|
| Tel: |
021-60345367 13916550749 |
| Email: |
sales@shzbio.com |
| Products Intro: |
Product Name:PD-1
Purity:> 99% Package:50ul/RMB 1098;100ul/RMB 1880;200ul/RMB 2900 Remarks:Programmed cell death protein 1; CD279; CD279 antigen; hPD 1; hPD-1; hSLE1; PD 1; PD1; PDCD 1; PDCD1; PDCD1_HUMAN; Programmed cell death 1; Protein PD 1; Protein PD-1; SLEB2; Syste
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
| Products Intro: |
Product Name:PD-1
Purity:95% SDS-PAGE Package:1mg;100ug
|
|
| | non A4 component of amyloid precursor, PARK1, PARK4, PD1, NACP (Non-a-beta component of Alzheimer disease amyloid, precursor) Basic information |
| Product Name: | non A4 component of amyloid precursor, PARK1, PARK4, PD1, NACP (Non-a-beta component of Alzheimer disease amyloid, precursor) | | Synonyms: | Anti-SNCA antibody produced in goat;CD279 (human): FC (human);PD1;α-Synuclein E46K human;non A4 component of amyloid precursor, PARK1, PARK4, PD1, NACP (Non-a-beta component of Alzheimer disease amyloid, precursor);PARK4;NACP (Non-a-beta component of Alzheimer disease amyloid, precursor);non A4 component of amyloid precursor | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![non A4 component of amyloid precursor, PARK1, PARK4, PD1, NACP (Non-a-beta component of Alzheimer disease amyloid, precursor) Structure]() |
| | non A4 component of amyloid precursor, PARK1, PARK4, PD1, NACP (Non-a-beta component of Alzheimer disease amyloid, precursor) Chemical Properties |
| storage temp. | -20°C | | form | lyophilized powder | | biological source | human |
| | non A4 component of amyloid precursor, PARK1, PARK4, PD1, NACP (Non-a-beta component of Alzheimer disease amyloid, precursor) Usage And Synthesis |
| Biochem/physiol Actions | Among the familial mutations of α-synuclein in Parkinson′s disease, E46K has the greatest potential to aggregate. This mutation is a 188G-A tran-sition resulting in a Glu46-to-Lys (E46K) substitution in the amino-terminal region of the protein. |
| | non A4 component of amyloid precursor, PARK1, PARK4, PD1, NACP (Non-a-beta component of Alzheimer disease amyloid, precursor) Preparation Products And Raw materials |
|